Literature DB >> 13780996

The use of live vaccine for vaccination of human beings against brucellosis in the USSR.

P A VERSHILOVA.   

Abstract

The great majority of human brucellosis cases in the USSR are caused by contact with infected sheep and goats. Extensive action has been taken to prevent human infection and to reduce the incidence among farm animals, the main prophylactic measure in recent years being vaccination with live brucellosis vaccine. The author summarizes the steps leading to the development of a satisfactory vaccine and gives a brief description of the method of preparation. Discussing the results obtained, she states that there has been a nearly 60% reduction in the number of human cases over the period 1952-58.The subcutaneous route of administration is usually resorted to, but preliminary figures suggest that cutaneous vaccination is equally effective immunogenically, although in persons who have suffered from active brucellosis it causes strong reactions and may lead to exacerbation of the disease. Research is going forward into the development of a cutaneous vaccine capable of general use.

Entities:  

Keywords:  BRUCELLOSIS/immunology

Mesh:

Substances:

Year:  1961        PMID: 13780996      PMCID: PMC2555373     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  13 in total

Review 1.  CURRENT ADVANCES IN BRUCELLOSIS RESEARCH.

Authors:  C A MANTHEI
Journal:  Public Health Rep       Date:  1964-12       Impact factor: 2.792

2.  Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).

Authors:  D L Hoover; R M Crawford; L L Van De Verg; M J Izadjoo; A K Bhattacharjee; C M Paranavitana; R L Warren; M P Nikolich; T L Hadfield
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 3.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

Review 4.  Brucellosis: the case for live, attenuated vaccines.

Authors:  Thomas A Ficht; Melissa M Kahl-McDonagh; Angela M Arenas-Gamboa; Allison C Rice-Ficht
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

5.  Immunization with viable Brucella organisms. Results of a safety test in humans.

Authors:  W W SPINK; J W HALL; J FINSTAD; E MALLET
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

6.  Pathogenicity and immunogenicity of streptomycin-dependent mutants of Brucella.

Authors:  E M SIMON; D T BERMAN
Journal:  J Bacteriol       Date:  1962-06       Impact factor: 3.490

7.  IMMUNIZATION AGAINST BRUCELLA INFECTION. 10. THE RELATIVE IMMUNOGENICITY OF BRUCELLA ABORTUS STRAIN 19-BA AND BRUCELLA MELITENSIS STRAIN REV I IN CYNOMOLGUS PHILIPPINENSIS.

Authors:  S S ELBERG; W K FAUNCE
Journal:  Bull World Health Organ       Date:  1964       Impact factor: 9.408

8.  Immunization against Brucella infection. 8. The response of Cynomolgus philippinensis, guinea-pigs and pregnant goats to injection by the Rev I strain of Brucella melitensis.

Authors:  S S ELBERG; W K FAUNCE
Journal:  Bull World Health Organ       Date:  1962       Impact factor: 9.408

9.  Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M.

Authors:  Mina J Izadjoo; Apurba K Bhattacharjee; Chrysanthi M Paranavitana; Ted L Hadfield; David L Hoover
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

10.  Resistance to transplanted cancer in mice increased by live Brucella vaccine.

Authors:  L Dazord; Y Le Garrec; C David; L Toujas
Journal:  Br J Cancer       Date:  1978-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.